The PI3K/Akt pathway: a target for curcumin's therapeutic effects

被引:0
|
作者
Aliyari, Mahdieh [1 ]
Ghoflchi, Sahar [1 ]
Hashemy, Seyed Isaac [1 ]
Hashemi, Seyedeh Fatemeh [2 ]
Reihani, Amirali [2 ]
Hosseini, Hossein [1 ,3 ]
机构
[1] Mashhad Univ Med Sci, Fac Med, Dept Clin Biochem, Mashhad, Iran
[2] Mashhad Univ Med Sci, Student Res Comm, Fac Med, Mashhad, Iran
[3] Mashhad Univ Med Sci, Metab Syndrome Res Ctr, Mashhad, Iran
关键词
Curcuma longa; Phosphoinositide; 3-kinase; Protein kinase B; Curcumin; Metabolic disease; Neurodegenerative disease; Kidney disorder; EPITHELIAL-MESENCHYMAL TRANSITION; FATTY LIVER-DISEASE; SIGNALING PATHWAY; ANTIINFLAMMATORY PROPERTIES; OXIDATIVE STRESS; NATURAL-PRODUCTS; PROTEIN-KINASE; HIGH GLUCOSE; INHIBITION; INJURY;
D O I
10.1007/s40200-025-01563-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PurposeThe purpose of this review study is to investigate the effect of curcumin on the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway in various diseases. Curcumin, the main compound found in turmeric, has attracted a lot of attention for its diverse pharmacological properties. These properties have increased the therapeutic potential of curcumin in chronic diseases such as cardiovascular disease, Type 2 diabetes, obesity, non-alcoholic fatty liver disease, kidney disease, and neurodegenerative diseases. One of the main mechanisms of the effect of curcumin on health is its ability to modulate the PI3K/Akt signaling pathway. This pathway plays an important role in regulating vital cellular processes such as growth, cell survival, metabolism, and apoptosis. Disruption of the PI3K/Akt signaling pathway is associated with the incidence of several diseases.MethodsElectronic databases including PubMed, Google Scholar, and Scopus were searched with the keywords "phosphoinositide 3-kinase" AND "protein kinase B "AND "curcumin" in the title/abstract. Also, following keywords "non-alcoholic fatty liver disease" AND "diabetes" AND "obesity" AND "kidney disease" and "neurodegenerative diseases" was searched in the whole text.ResultsResearch indicates that curcumin offers potential benefits for several health conditions. Studies have shown it can help regulate blood sugar, reduce inflammation, and protect the heart, kidneys, and brain.ConclusionThis protective effect is partially achieved by regulating the PI3K-Akt survival pathway, which helps improve metabolic disorders and oxidative stress. By examining how curcumin affects this vital cell pathway, researchers can discover new treatment strategies for a range of diseases.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] PI3K/AKT/mTOR pathway in angiogenesis
    Karar, Jayashree
    Maity, Amit
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2011, 4
  • [32] Activation of the PI3K/Akt pathway in neuroblastoma
    Sartelet, Herve
    Castaing, Marine
    Fabre, Monique
    Bosq, Jacques
    Rougemont, Anne-Laure
    Michieis, Stefan
    Vassal, Gilles
    VIRCHOWS ARCHIV, 2007, 451 (02) : 130 - 130
  • [33] The PI3K/Akt/mTOR signaling pathway
    Dennis, P. A.
    ANNALS OF ONCOLOGY, 2011, 22 : 19 - 19
  • [34] Overview of the PI3K/Akt/mTOR pathway
    Dennis, P. A.
    ANNALS OF ONCOLOGY, 2008, 19 : 21 - 21
  • [35] Activation of the PI3K/Akt pathway in neuroblastoma
    Sartelet, H.
    Castain, M.
    Fabre, M.
    Bosq, J.
    Rougemont, A.
    Michiels, S.
    Vassal, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [36] The PI3K/AKT/mTOR interactive pathway
    Ersahin, Tulin
    Tuncbag, Nurcan
    Cetin-Atalay, Rengul
    MOLECULAR BIOSYSTEMS, 2015, 11 (07) : 1946 - 1954
  • [37] PI3K/Akt signalling pathway and cancer
    Vara, JAF
    Casado, E
    de Castro, J
    Cejas, P
    Belda-Iniesta, C
    González-Barón, M
    CANCER TREATMENT REVIEWS, 2004, 30 (02) : 193 - 204
  • [38] PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment
    Leiphrakpam, Premila D.
    Are, Chandrakanth
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (06)
  • [39] The PI3K/Akt/mTOR pathway as a preventive target in melanoma brain metastasis
    Tehranian, Cedric
    Fankhauser, Laura
    Harter, Patrick N.
    Ratcliffe, Colin D. H.
    Zeiner, Pia S.
    Messmer, Julia M.
    Hoffmann, Dirk C.
    Frey, Katharina
    Westphal, Dana
    Ronellenfitsch, Michael W.
    Sahai, Erik
    Wick, Wolfgang
    Karreman, Matthia A.
    Winkler, Frank
    NEURO-ONCOLOGY, 2022, 24 (02) : 213 - 225
  • [40] Somatic overgrowth disorders of the PI3K/AKT/mTOR pathway & therapeutic strategies
    Keppler-Noreuil, Kim M.
    Parker, Victoria E. R.
    Darling, Thomas N.
    Martinez-Agosto, Julian A.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS, 2016, 172 (04) : 402 - 421